Dublin, Dec. 19, 2018 (GLOBE NEWSWIRE) -- The "Global Ocular Inflammation Treatment Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

The ocular inflammation treatment market will register a CAGR of more than 6% by 2023.

The technological advances in drug delivery to push growth in the market. The increasing need for novel drug delivery systems has led to the advent of intravitreal implants, which are small hair-stranded sized devices that are implanted into the middle layer of the eye.

Growing awareness of eye care

Several organizations are conducting awareness campaigns on various eye-related diseases. Thus, the rising awareness about eye related diseases, including ocular inflammation is expected to contribute to the market growth during the forecast period.

Growing preference for surgeries

The global ocular inflammation market poses high threat from alternative treatment options such as non-invasive surgeries such as LASER treatments and invasive surgeries such as vitrectomy.

Key Players

• AbbVie
• Allergan
• Bausch Health
• Novartis
• Pfizer

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 04: MARKET SIZING

• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

PART 06: MARKET SEGMENTATION BY PRODUCT

• Market segmentation by product
• Comparison by product
• Corticosteroids - Market size and forecast 2018-2023
• Immunosuppressants - Market size and forecast 2018-2023
• Anti-infectives - Market size and forecast 2018-2023
• Other drug classes - Market size and forecast 2018-2023
• Market opportunity by product

PART 07: MARKET SEGMENTATION BY ROA

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

• Geographic segmentation
• Geographic comparison
• Americas - Market size and forecast 2018-2023
• EMEA - Market size and forecast 2018-2023
• APAC - Market size and forecast 2018-2023
• Key leading countries
• Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

PART 12: MARKET TRENDS

PART 13: VENDOR LANDSCAPE

• Overview
• Landscape disruption

PART 14: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors
• AbbVie
• Allergan
• Bausch Health
• Novartis
• Pfizer

For more information about this report visit https://www.researchandmarkets.com/research/n5t9qr/ocular?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Optical , Optical Disorders Drugs